|
|
|
Insider
Information: |
Clark Paul N |
Relationship: |
Director |
City: |
Bothell |
State: |
WA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
6 |
|
Direct
Shares |
277,800 |
|
Indirect Shares
|
1,605,470 |
|
|
Direct
Value |
$22,614,505 |
|
|
Indirect Value
|
$140,228 |
|
|
Total
Shares |
1,883,270 |
|
|
Total
Value |
$22,754,733 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Agilent Technologies Inc |
A |
Director |
2021-03-18 |
95,234 |
2006-05-17 |
0 |
Premium* |
|
Amylin Pharmaceuticals Inc |
AMLN |
Director |
2011-05-24 |
3,000 |
2011-05-24 |
1,908 |
Premium* |
|
Talecris Biotherapeutics Holding... |
TLCR |
Director |
2009-09-30 |
9,696 |
2011-06-01 |
0 |
Premium* |
|
Biolase Inc |
BIOL |
Director |
2017-06-30 |
96,250 |
2017-06-30 |
1,532,757 |
Premium* |
|
Keysight Technologies Inc |
KEYS |
Director |
2021-03-19 |
73,620 |
2014-11-05 |
0 |
Premium* |
|
Agenus Inc |
AGEN |
Director |
|
0 |
2020-08-27 |
70,805 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
60 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 2 of 3
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
A |
Agilent Technologies Inc |
Director |
|
2014-03-20 |
4 |
A |
$56.69 |
$278,501 |
D/D |
4,913 |
57,230 |
0 |
- |
|
BIOL |
Biolase Inc |
Director |
|
2014-06-12 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
85,121 |
|
- |
|
BIOL |
Biolase Inc |
Director |
|
2014-07-22 |
4 |
B |
$1.92 |
$999,999 |
I/I |
520,833 |
605,954 |
2.1 |
- |
|
BIOL |
Biolase Inc |
Director |
|
2014-11-03 |
4 |
B |
$2.39 |
$967,121 |
I/I |
404,653 |
1,010,607 |
2.1 |
- |
|
KEYS |
Keysight Technologies Inc |
Director |
|
2014-11-05 |
4 |
A |
$0.00 |
$0 |
D/D |
8,766 |
9,148 |
0 |
- |
|
KEYS |
Keysight Technologies Inc |
Director |
|
2015-01-22 |
4 |
A |
$35.78 |
$89,005 |
D/D |
2,488 |
18,185 |
0 |
- |
|
KEYS |
Keysight Technologies Inc |
Director |
|
2015-01-22 |
4 |
A |
$0.00 |
$0 |
D/D |
1,756 |
10,904 |
0 |
- |
|
A |
Agilent Technologies Inc |
Director |
|
2015-03-04 |
4 |
OE |
$13.89 |
$776,915 |
D/D |
37,973 |
116,774 |
0 |
- |
|
A |
Agilent Technologies Inc |
Director |
|
2015-03-04 |
4 |
S |
$41.87 |
$1,589,930 |
D/D |
(37,973) |
78,801 |
0 |
- |
|
A |
Agilent Technologies Inc |
Director |
|
2015-03-19 |
4 |
A |
$42.21 |
$283,069 |
D/D |
6,706 |
85,507 |
0 |
- |
|
KEYS |
Keysight Technologies Inc |
Director |
|
2015-03-20 |
4 |
A |
$38.74 |
$263,081 |
D/D |
6,791 |
24,976 |
0 |
- |
|
KEYS |
Keysight Technologies Inc |
Director |
|
2015-03-20 |
4 |
A |
$0.00 |
$0 |
D/D |
4,793 |
15,697 |
0 |
- |
|
BIOL |
Biolase Inc |
Director |
|
2015-08-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,217 |
1,020,678 |
0 |
- |
|
BIOL |
Biolase Inc |
Director |
|
2015-11-09 |
4 |
B |
$0.75 |
$26,556 |
I/I |
34,579 |
1,055,257 |
2.1 |
- |
|
BIOL |
Biolase Inc |
Director |
|
2015-11-10 |
4 |
B |
$0.73 |
$74,842 |
I/I |
100,000 |
1,155,257 |
2.1 |
- |
|
A |
Agilent Technologies Inc |
Director |
|
2016-03-17 |
4 |
A |
$39.29 |
$184,820 |
D/D |
4,704 |
91,102 |
0 |
- |
|
KEYS |
Keysight Technologies Inc |
Director |
|
2016-03-17 |
4 |
A |
$25.98 |
$434,989 |
D/D |
16,743 |
41,719 |
0 |
- |
|
BIOL |
Biolase Inc |
Director |
|
2016-09-30 |
4 |
OE |
$1.13 |
$249,956 |
I/I |
221,200 |
221,200 |
0 |
- |
|
A |
Agilent Technologies Inc |
Director |
|
2016-11-18 |
4 |
S |
$45.31 |
$213,138 |
D/D |
(4,704) |
87,074 |
0 |
- |
|
A |
Agilent Technologies Inc |
Director |
|
2017-03-16 |
4 |
A |
$53.05 |
$205,091 |
D/D |
3,866 |
91,179 |
0 |
- |
|
KEYS |
Keysight Technologies Inc |
Director |
|
2017-03-17 |
4 |
A |
$39.02 |
$445,126 |
D/D |
11,408 |
53,126 |
0 |
- |
|
BIOL |
Biolase Inc |
Director |
|
2017-05-08 |
4 |
OE |
$0.00 |
$0 |
D/D |
96,250 |
96,250 |
0 |
- |
|
A |
Agilent Technologies Inc |
Director |
|
2017-05-25 |
4 |
S |
$59.05 |
$228,287 |
D/D |
(3,866) |
87,520 |
0 |
- |
|
BIOL |
Biolase Inc |
Director |
|
2017-06-30 |
4 |
OE |
$1.24 |
$193,812 |
I/I |
156,300 |
1,311,557 |
0 |
- |
|
A |
Agilent Technologies Inc |
Director |
|
2018-03-22 |
4 |
A |
$67.47 |
$194,044 |
D/D |
2,876 |
90,929 |
0 |
- |
|
60 Records found
|
|
Page 2 of 3 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|